Exodus Point Capital Management, LP Spring Works Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 142,355 shares of SWTX stock, worth $4.65 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
142,355
Previous 33,471
325.31%
Holding current value
$4.65 Million
Previous $1.65 Million
225.62%
% of portfolio
0.04%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding SWTX
# of Institutions
220Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$214 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$183 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$121 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$118 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$112 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.04B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...